EMEA (Europe, Middle East and Africa) Biosimilar Market Report 2017

August 2017 | 104 pages | ID: E148166FEBAEN
QYResearch

Abstracts

In this report, the EMEA Biosimilar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Biosimilar for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Biosimilar market competition by top manufacturers/players, with Biosimilar sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Roche
• Eli Lilly
• Bayer
• Amgen
• Sanofi-Aventis
• Johnson & Johnson
• Novo Nordisk
• Merck

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Antibody
• Hormone
• Growth Factors
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Biosimilar for each application, including

• Tumor
• Diabetes
• Cardiovascular
• Hemophilia
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Biosimilar Market Report 2017

1 BIOSIMILAR OVERVIEW

1.1 Product Overview and Scope of Biosimilar
1.2 Classification of Biosimilar
  1.2.1 EMEA Biosimilar Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Biosimilar Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Antibody
  1.2.4 Hormone
  1.2.5 Growth Factors
  1.2.6 Other
1.3 EMEA Biosimilar Market by Application/End Users
  1.3.1 EMEA Biosimilar Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Tumor
  1.3.3 Diabetes
  1.3.4 Cardiovascular
  1.3.5 Hemophilia
  1.3.6 Other
1.4 EMEA Biosimilar Market by Region
  1.4.1 EMEA Biosimilar Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Biosimilar (2012-2022)
  1.5.1 EMEA Biosimilar Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Biosimilar Revenue and Growth Rate (2012-2022)

2 EMEA BIOSIMILAR COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Biosimilar Market Competition by Players/Manufacturers
  2.1.1 EMEA Biosimilar Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Biosimilar Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Biosimilar Sale Price by Players (2012-2017)
2.2 EMEA Biosimilar (Volume and Value) by Type/Product Category
  2.2.1 EMEA Biosimilar Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Biosimilar Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Biosimilar Sale Price by Type (2012-2017)
2.3 EMEA Biosimilar (Volume) by Application
2.4 EMEA Biosimilar (Volume and Value) by Region
  2.4.1 EMEA Biosimilar Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Biosimilar Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Biosimilar Sales Price by Region (2012-2017)

3 EUROPE BIOSIMILAR (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Biosimilar Sales and Value (2012-2017)
  3.1.1 Europe Biosimilar Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Biosimilar Revenue and Growth Rate (2012-2017)
3.2 Europe Biosimilar Sales and Market Share by Type
3.3 Europe Biosimilar Sales and Market Share by Application
3.4 Europe Biosimilar Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Biosimilar Sales Volume by Countries (2012-2017)
  3.4.2 Europe Biosimilar Revenue by Countries (2012-2017)
  3.4.3 Germany Biosimilar Sales and Growth Rate (2012-2017)
  3.4.4 France Biosimilar Sales and Growth Rate (2012-2017)
  3.4.5 UK Biosimilar Sales and Growth Rate (2012-2017)
  3.4.6 Russia Biosimilar Sales and Growth Rate (2012-2017)
  3.4.7 Italy Biosimilar Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Biosimilar Sales and Growth Rate (2012-2017)

4 MIDDLE EAST BIOSIMILAR (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Biosimilar Sales and Value (2012-2017)
  4.1.1 Middle East Biosimilar Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Biosimilar Revenue and Growth Rate (2012-2017)
4.2 Middle East Biosimilar Sales and Market Share by Type
4.3 Middle East Biosimilar Sales and Market Share by Application
4.4 Middle East Biosimilar Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Biosimilar Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Biosimilar Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Biosimilar Sales and Growth Rate (2012-2017)
  4.4.4 Israel Biosimilar Sales and Growth Rate (2012-2017)
  4.4.5 UAE Biosimilar Sales and Growth Rate (2012-2017)
  4.4.6 Iran Biosimilar Sales and Growth Rate (2012-2017)

5 AFRICA BIOSIMILAR (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Biosimilar Sales and Value (2012-2017)
  5.1.1 Africa Biosimilar Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Biosimilar Revenue and Growth Rate (2012-2017)
5.2 Africa Biosimilar Sales and Market Share by Type
5.3 Africa Biosimilar Sales and Market Share by Application
5.4 Africa Biosimilar Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Biosimilar Sales Volume by Countries (2012-2017)
  5.4.2 Africa Biosimilar Revenue by Countries (2012-2017)
  5.4.3 South Africa Biosimilar Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Biosimilar Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Biosimilar Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Biosimilar Sales and Growth Rate (2012-2017)

6 EMEA BIOSIMILAR MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Biosimilar Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Roche
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Biosimilar Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Roche Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eli Lilly
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Biosimilar Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eli Lilly Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Bayer
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Biosimilar Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Bayer Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Amgen
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Biosimilar Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Amgen Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Sanofi-Aventis
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Biosimilar Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sanofi-Aventis Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Johnson & Johnson
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Biosimilar Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Johnson & Johnson Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Novo Nordisk
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Biosimilar Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Novo Nordisk Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Merck
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Biosimilar Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Merck Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 BIOSIMILAR MANUFACTURING COST ANALYSIS

7.1 Biosimilar Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biosimilar

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Biosimilar Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biosimilar Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA BIOSIMILAR MARKET FORECAST (2017-2022)

11.1 EMEA Biosimilar Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Biosimilar Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Biosimilar Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Biosimilar Price and Trend Forecast (2017-2022)
11.2 EMEA Biosimilar Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Biosimilar Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Biosimilar Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Biosimilar Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Biosimilar Sales Forecast by Type (2017-2022)
11.7 EMEA Biosimilar Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Biosimilar
Figure EMEA Biosimilar Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Biosimilar Sales Volume Market Share by Type (Product Category) in 2016
Figure Antibody Product Picture
Figure Hormone Product Picture
Figure Growth Factors Product Picture
Figure Other Product Picture
Figure EMEA Biosimilar Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Biosimilar by Application in 2016
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Hemophilia Examples
Table Key Downstream Customer in Hemophilia
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Biosimilar Market Size (Million USD) by Region (2012-2022)
Figure Europe Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biosimilar Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Biosimilar Revenue (Million USD) Status and Forecast by Countries
Figure Africa Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Biosimilar Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Biosimilar Sales Volume and Growth Rate (2012-2022)
Figure EMEA Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Biosimilar Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Biosimilar Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Biosimilar Sales Share by Players (2012-2017)
Figure 2016 Biosimilar Sales Share by Players
Figure 2017 Biosimilar Sales Share by Players
Figure EMEA Biosimilar Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Biosimilar Revenue (Million USD) by Players (2012-2017)
Table EMEA Biosimilar Revenue Share by Players (2012-2017)
Table 2016 EMEA Biosimilar Revenue Share by Players
Table 2017 EMEA Biosimilar Revenue Share by Players
Table EMEA Biosimilar Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Biosimilar Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Biosimilar Sales Share by Type (2012-2017)
Figure Sales Market Share of Biosimilar by Type (2012-2017)
Figure EMEA Biosimilar Sales Market Share by Type (2012-2017)
Table EMEA Biosimilar Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Biosimilar Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimilar by Type in 2016
Table EMEA Biosimilar Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Biosimilar Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Biosimilar Sales Share by Application (2012-2017)
Figure Sales Market Share of Biosimilar by Application (2012-2017)
Figure EMEA Biosimilar Sales Market Share by Application in 2016
Table EMEA Biosimilar Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Biosimilar Sales Share by Region (2012-2017)
Figure Sales Market Share of Biosimilar by Region (2012-2017)
Figure EMEA Biosimilar Sales Market Share in 2016
Table EMEA Biosimilar Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Biosimilar Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Biosimilar by Region (2012-2017)
Figure EMEA Biosimilar Revenue Market Share Regions in 2016
Table EMEA Biosimilar Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Biosimilar Revenue and Growth Rate (2012-2017)
Table Europe Biosimilar Sales (K Units) by Type (2012-2017)
Table Europe Biosimilar Market Share by Type (2012-2017)
Figure Europe Biosimilar Market Share by Type in 2016
Table Europe Biosimilar Sales (K Units) by Application (2012-2017)
Table Europe Biosimilar Market Share by Application (2012-2017)
Figure Europe Biosimilar Market Share by Application in 2016
Table Europe Biosimilar Sales (K Units) by Countries (2012-2017)
Table Europe Biosimilar Sales Market Share by Countries (2012-2017)
Figure Europe Biosimilar Sales Market Share by Countries (2012-2017)
Figure Europe Biosimilar Sales Market Share by Countries in 2016
Table Europe Biosimilar Revenue (Million USD) by Countries (2012-2017)
Table Europe Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Europe Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Europe Biosimilar Revenue Market Share by Countries in 2016
Figure Germany Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure France Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure UK Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Biosimilar Sales (K Units) by Type (2012-2017)
Table Middle East Biosimilar Market Share by Type (2012-2017)
Figure Middle East Biosimilar Market Share by Type (2012-2017)
Table Middle East Biosimilar Sales (K Units) by Applications (2012-2017)
Table Middle East Biosimilar Market Share by Applications (2012-2017)
Figure Middle East Biosimilar Sales Market Share by Application in 2016
Table Middle East Biosimilar Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Biosimilar Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Biosimilar Sales Volume Market Share by Countries in 2016
Table Middle East Biosimilar Revenue (Million USD) by Countries (2012-2017)
Table Middle East Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Middle East Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Middle East Biosimilar Revenue Market Share by Countries in 2016
Figure Saudi Arabia Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Biosimilar Sales (K Units) by Type (2012-2017)
Table Africa Biosimilar Sales Market Share by Type (2012-2017)
Figure Africa Biosimilar Sales Market Share by Type (2012-2017)
Figure Africa Biosimilar Sales Market Share by Type in 2016
Table Africa Biosimilar Sales (K Units) by Application (2012-2017)
Table Africa Biosimilar Sales Market Share by Application (2012-2017)
Figure Africa Biosimilar Sales Market Share by Application (2012-2017)
Table Africa Biosimilar Sales Volume (K Units) by Countries (2012-2017)
Table Africa Biosimilar Sales Market Share by Countries (2012-2017)
Figure Africa Biosimilar Sales Market Share by Countries (2012-2017)
Figure Africa Biosimilar Sales Market Share by Countries in 2016
Table Africa Biosimilar Revenue (Million USD) by Countries (2012-2017)
Table Africa Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Africa Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Africa Biosimilar Revenue Market Share by Countries in 2016
Figure South Africa Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Table Pfizer Biosimilar Basic Information List
Table Pfizer Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Pfizer Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Roche Biosimilar Basic Information List
Table Roche Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Roche Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Biosimilar Basic Information List
Table Eli Lilly Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Bayer Biosimilar Basic Information List
Table Bayer Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Bayer Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Amgen Biosimilar Basic Information List
Table Amgen Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Amgen Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Sanofi-Aventis Biosimilar Basic Information List
Table Sanofi-Aventis Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi-Aventis Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Sanofi-Aventis Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Biosimilar Basic Information List
Table Johnson & Johnson Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Novo Nordisk Biosimilar Basic Information List
Table Novo Nordisk Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Novo Nordisk Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Merck Biosimilar Basic Information List
Table Merck Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Merck Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar
Figure Manufacturing Process Analysis of Biosimilar
Figure Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Major Manufacturers in 2016
Table Major Buyers of Biosimilar
Table Distributors/Traders List
Figure EMEA Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Biosimilar Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Biosimilar Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Biosimilar Sales Market Share Forecast by Region (2017-2022)
Table EMEA Biosimilar Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Biosimilar Revenue Market Share Forecast by Region (2017-2022)
Table Europe Biosimilar Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Biosimilar Sales Market Share Forecast by Countries (2017-2022)
Table Europe Biosimilar Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Biosimilar Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Biosimilar Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Biosimilar Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Biosimilar Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Biosimilar Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Biosimilar Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Biosimilar Sales Market Share Forecast by Countries (2017-2022)
Table Africa Biosimilar Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Biosimilar Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Biosimilar Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Biosimilar Sales Market Share Forecast by Type (2017-2022)
Table EMEA Biosimilar Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Biosimilar Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources